Skip to main content

Table 2 Randomized Placebo-Controlled Clinical Trials on Prevention of Eczema by Probiotics in High-Risk Infants

From: Probiotics in the Treatment and Prevention of Allergy in Children

Study

No. Patients

Treatment Initiated

Follow-up (years)

Intervention and Amount of Probiotics (cfu) in the Active Group

Incidence of Eczema A/C

Effect on Eczema OR (95% CI)

Effect on IgE-Associated Eczema OR (95% CI)

Kalliomäki et al (2001)[40]

A = 77

Pregnant women and newborn babies

2

L. rhamnosus GG 1 × 1010 2 to 4 weeks before delivery, 6 months after birth to lactating mothers, otherwise to bottle-fed infants

23% vs 46%

0.36

NA

 

C = 82

    

(0.17-0.77)

--

Kalliomäki et al (2003)[41]

A = 53

 

4

 

26% vs 46%

0.42

--

 

C = 54

    

(0.18-0.94)

--

Kalliomäki et al (2007)[42]

A = 53

 

7

 

43% vs 66%

0.58

--

 

C = 62

    

(0.35-0.94)

--

Kukkonen et al (2007)[47]

A = 461

Pregnant women and newborn babies

2

L. rhamnosus GG 5 × 109, L. rhamnosus LC705 5 × 109, B. breve Bb99 2 × 108, and P. freudenreichii ssp shermanii JS 2 × 109 plus prebiotic galacto-oligosaccharides from 36 gw daily for 6 months after birth

26% vs 32%

0.74

0.66

 

C = 464

    

(0.55-0.98)

(0.46-0.95)

Kuitunen et al (2009)[48]

A = 445

 

5

 

39% vs 43%

0.85

--

 

C = 446

    

(0.65-1.11)

--

Taylor et al (2007)[44]

High risk

Only newborn babies aged < 48 hours

1

L. acidophilus 3 × 109 daily for 6 months after birth

43% vs 39%

1.18

2.18

 

A = 89

    

(0.64-2.16)

(1.01-4.72)

 

C = 88

    

--

--

Abrahamsson et al (2007)[45]

High risk

Pregnant women and newborn babies

2

L. reuteri 1 × 108 from 36 gw daily to 12 months after birth

36% vs 34%

1.06

0.53

 

A = 95

    

(0.58-1.93)

(0.24-1.16)

 

C = 93

    

--

--

Kopp et al (2008)[43]

High risk

Pregnant women and newborn babies

2

L. rhamnosus GG 5 × 109 daily 4 to 6 weeks before delivery, 6 months after birth to lactating mothers, otherwise to bottle-fed infants

28% vs 27%

1.04

NA

 

A = 50

    

(0.42-2.57)

--

 

C = 44

    

--

--

Wickens et al (2008)[46]

High risk

Pregnant women and newborn babies

2

A1: L. rhamnosus HN001 6 × 109

A2: B. animalis ssp lactis 9 × 109 from 35 gw daily for 24 months after birth

15% vs 27%

0.51

0.51

 

A1 = 144

    

(0.3-0.85)

(0.27-0.87)

 

A2 = 152

      
 

C = 150

      
  1. A, active treatment group; C, control; cfu, colony-forming units.